Organization | Farmoquimica S.A.

Farmoquimica S.A. Report issue

For profit Phase 2 Phase 3

Founded: Rio de Janeiro Brazil (1932)

Status: No NME R&D (1932)

Organization Overview

First Clinical Trial

2012

NCT00980876

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Farmoquimica S.A.

Active Ingredients

Drugs in Phase 3 Trials (8)

acetaminophen (tylenol) (1 trial)

caffeine (1 trial)

carisoprodol (soma) (1 trial)

ciprofloxacin (cipro) (1 trial)

clonidine (catapres) (1 trial)

diclofenac (voltaren) (1 trial)

nitazoxanide (Alinia) (4 trials)

Drugs in Phase 2 Trials (1)

imiquimod (aldara) (1 trial)

Drugs in Other Trials (3)

lactobacillus delbrueckii (1 trial)

niacinamide (1 trial)

saccharide isomerate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Back Pain (Phase 3)

Low Back Pain (Phase 3)

Neoplasms (Phase 2)

Otitis (Phase 3)

Otitis Externa (Phase 3)

Uterine Cervical Neoplasms (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 9
# of Trial APIs: 12